SI1229936T1 - Use of anti-idiotypical antibodies as vaccines against cancer - Google Patents
Use of anti-idiotypical antibodies as vaccines against cancerInfo
- Publication number
- SI1229936T1 SI1229936T1 SI200030390T SI200030390T SI1229936T1 SI 1229936 T1 SI1229936 T1 SI 1229936T1 SI 200030390 T SI200030390 T SI 200030390T SI 200030390 T SI200030390 T SI 200030390T SI 1229936 T1 SI1229936 T1 SI 1229936T1
- Authority
- SI
- Slovenia
- Prior art keywords
- against cancer
- vaccines against
- idiotypical antibodies
- idiotypical
- antibodies
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0192799A AT409086B (en) | 1999-11-16 | 1999-11-16 | NEW USE OF ANTIBODIES AS VACCINE |
EP00987250A EP1229936B1 (en) | 1999-11-16 | 2000-11-15 | Use of anti-idiotypical antibodies as vaccines against cancer |
PCT/EP2000/011306 WO2001035989A2 (en) | 1999-11-16 | 2000-11-15 | Use of anti-idiotypical antibodies as vaccines against cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1229936T1 true SI1229936T1 (en) | 2004-08-31 |
Family
ID=32470971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200030390T SI1229936T1 (en) | 1999-11-16 | 2000-11-15 | Use of anti-idiotypical antibodies as vaccines against cancer |
Country Status (2)
Country | Link |
---|---|
AT (1) | ATE267020T1 (en) |
SI (1) | SI1229936T1 (en) |
-
2000
- 2000-11-15 SI SI200030390T patent/SI1229936T1/en unknown
- 2000-11-15 AT AT00987250T patent/ATE267020T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE267020T1 (en) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202885A3 (en) | Vaccines | |
IL145043A0 (en) | Vaccine | |
HUP0204250A3 (en) | Use of hiv-protein or -polynucleotide for vaccine produce | |
HUS1300072I1 (en) | Vaccine | |
IL158107A0 (en) | Human papillomaviruses vaccine | |
HUP0200527A2 (en) | Use of antibodies for anticancer vaccination | |
PL356770A1 (en) | Use of anti-idiotypical antibodies as vaccines against cancer | |
GB9901254D0 (en) | Vaccines | |
GB9915204D0 (en) | Vaccine | |
SI1229936T1 (en) | Use of anti-idiotypical antibodies as vaccines against cancer | |
GB9906437D0 (en) | Vaccine | |
GB0105606D0 (en) | Immunogens and vaccines and their preparation and use | |
GB9913327D0 (en) | Vaccine | |
AU2002354943A1 (en) | Haptenizing cancer cell components for the preparation of cancer vaccines | |
GB9915419D0 (en) | Antigens | |
GB9922700D0 (en) | Vaccine | |
GB9909072D0 (en) | Vaccine | |
GB9929923D0 (en) | Antigen preparations | |
GB9914057D0 (en) | Antibody therapy | |
GB9921242D0 (en) | Cancer vaccine and diagnosis | |
GB9921046D0 (en) | Therapeutic antibody composition & use | |
GB9812316D0 (en) | Cancer vaccines | |
GB9904280D0 (en) | Vaccines | |
GB9909466D0 (en) | Vaccines | |
GB9904048D0 (en) | Vaccines |